Overview

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer

Status:
Completed
Trial end date:
2019-06-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect some parameters which may help to provide guidance on how Androgen Deprivation Therapy (ADT) drugs are renewed and physician satisfaction.
Details
Lead Sponsor:
Ipsen
Treatments:
Triptorelin Pamoate